PharmaShots Interview: Janssen’s Mark Wildgust Shares Insights on Imbruvica for Chronic Lymphocytic Leukemia and Darzalex for Mult...
May 2, 2022
Sanofi's Sarclisa Combination Regimen Receives Health Canada's Approval for Multiple Myeloma
October 13, 2021
SpringWorks Collaborates with Dana-Farber to Evaluate Nirogacestat in Multiple Myeloma
August 30, 2021
BMS' Abecma (Idecabtagene Vicleucel) Receives EC's Conditional Approval for Relapsed and Refractory Multiple Myeloma
August 20, 2021
C4T's CFT7455 Receives the US FDA's Orphan Drug designation for the Treatment of Multiple Myeloma
August 12, 2021
Janssen's Darzalex Faspro (daratumumab and hyaluronidase-fihj) + Pomalidomide and Dexamethasone Receive the US FDA's Approval to T...
July 13, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.